A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 11
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NRI
Long Form : nonresponder imputation
No. Year Title Co-occurring Abbreviation
2019 Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks. PYs
2019 SLE clinical trials: impact of missing data on estimating treatment effects. CC, LOCF, MI, MMF, SOC, SRI-5
2019 The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn's disease: a post hoc analysis. ---
2018 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. CZP, LOCF, OL, PsA, TNF
2018 Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years. IGA, PASI, TFR
2018 Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III. AEs, BCVA, TF
2018 Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. VDZ
2017 ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY. LOCF, Mayo score, TNF-alpha
2017 Methods for Imputing Missing Efficacy Data in Clinical Trials of Biologic Psoriasis Therapies: Implications for Interpretations of Trial Results. LOCF, MI, PASI
10  2014 Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3. IBDQ, LOCF, UC
11  2010 Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study. DAS28, MTX